DEEPAKNTR - Deepak Nitrite Limited Share Price

Chemicals & Petrochemicals

₹1978.00+16.70(+0.85%)

Market Closed as of Apr 28, 2025, 15:30 IST

What does Deepak Nitrite Limited do?

Specialty Chemicals•Chemicals•Mid Cap

Deepak Nitrite is a prominent Specialty Chemicals company, listed under the stock ticker DEEPAKNTR. With a substantial market capitalization of Rs. 27,128.6 Crores, it specializes in the manufacture, trade, and sale of chemical intermediates both within India and internationally.

The company operates through two main segments: Advanced Intermediates and Phenolics. Its diverse product portfolio includes:

Chemical Intermediates: Sodium nitrite, sodium nitrate, nitro toluidines, fuel additives, nitrosyl sulphuric acid, xylidines, oximes, cumidines, and speciality agrochemicals.
Products for Various Industries: Optical brightening agents, DASDA, and benzotrifluoride used in the colorants, dyes, rubber, paper, pharmaceuticals, and textiles industries.

Additionally, Deepak Nitrite provides crucial chemicals such as cumene, phenol, acetone, isopropyl alcohol, and alpha methyl styrene for applications across laminate and plywood, automotive, construction, pharmaceuticals, and more.

The company has a comprehensive product range, including deepwhite powders and liquids, various nitrotoluidines, and protective products that cater to a wide array of industries. It also engages in project engineering, procurement, construction, commissioning, management, and consultancy services.

Founded in 1970 and headquartered in Vadodara, India, Deepak Nitrite has demonstrated impressive performance with a trailing 12-month revenue of Rs. 8,308.7 Crores. The company is committed to delivering value to its investors, illustrated by a dividend yield of 0.34% per year, paying out Rs. 7.5 as a dividend per share over the past year. Notably, it has achieved a 29% revenue growth over the last three years.

Industry Group:Chemicals & Petrochemicals

Employees:1,720

Website:www.godeepak.com

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Rank

Balance Sheet

Momentum

Technicals

Smart Money

Insider Trading

Category	DEEPAKNTR	Chemicals
PE	35.73	54.41
PS	3.22	4.58
Growth	9.4 %	7.3 %

Share Holdings

Understand Deepak Nitrite ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Major Shareholders

Share Holding Details

As of 2025-03-31

Shareholder Name	Holding %
Deepak Chimanlal Mehta	16.52%
Life Insurance Corporation Of India	9.47%
Stiffen Credits And Capital Pvt Ltd	6.19%
Checkpoint Credits And Capital Pvt Ltd	5.28%
Stepup Credits And Capital Pvt Ltd	5.07%
Stigma Credits And Capital P Ltd	4.54%
Deepak Novochem Technologies Limited	3.41%
Kotak Emerging Equity Scheme	3.17%
Skyrose Finvest Pvt Ltd	2.81%
Franklin India Smaller Companies Fund	2.39%
Mirae Asset Large & Midcap Fund	1.92%
Pranawa Leafin Pvt Ltd	1.69%
Forex Leafin Pvt Ltd	1.59%
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund	1.29%
Storewell Credits And Capital Private Ltd	0.65%
Sundown Finvest Pvt Ltd	0.61%
Ila Deepak Mehta	0.44%
Hardik Leafin Pvt Ltd	0.25%
Maulik Deepak Mehta	0.1%
Prahaan Maulik Mehta	0.03%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Valuation
Market Cap	26.98 kCr
Price/Earnings (Trailing)	36.03
Price/Sales (Trailing)	3.25
EV/EBITDA	21.82
Price/Free Cashflow	250.74
MarketCap/EBT	26.37

Fundamentals
Revenue (TTM)	8.31 kCr
Rev. Growth (Yr)	-4.86%
Rev. Growth (Qtr)	-6.28%
Earnings (TTM)	748.71 Cr
Earnings Growth (Yr)	-51.43%
Earnings Growth (Qtr)	-49.47%

Profitability
Operating Margin	11.35%
EBT Margin	12.31%
Return on Equity	14.61%
Return on Assets	10.68%
Free Cashflow Yield	0.40%

Income Statement for Deepak Nitrite

Standalone figures (in Rs. Crores) / View Consolidated Data

QuarterlyAnnual

Description	(%) Q/Q	Dec-2024	Sep-2024	Jun-2024	Mar-2024	Dec-2023	Sep-2023
Revenue From Operations	-8.8%	552	605	716	671	674	671
Other Income	-93.9%	7.68	110	14	17	11	89
Total Income	-21.7%	559	714	729	689	685	760
Cost of Materials	-9.9%	338	375	367	356	371	355
Employee Expense	-7.2%	65	70	70	67	60	61
Finance costs	64.3%	0.95	0.86	0.95	0.81	0.4	0.28
Depreciation and Amortization	0%	25	25	24	24	22	21
Other expenses	-6.4%	133	142	149	136	129	125
Total Expenses	-3.8%	535	556	644	612	585	574
Profit Before exceptional items and Tax	-85.4%	24	158	85	77	100	186
Exceptional items before tax	-	0	0	0	80	0	0
Total profit before tax	-85.4%	24	158	85	157	100	186
Current tax	-71.7%	5.24	16	22	39	29	31
Deferred tax	139.6%	1.36	0.09	-0.28	2.39	-3.7	-1.88
Total tax	-62.7%	6.6	16	22	41	26	29
Total profit (loss) for period	-88.7%	17	142	63	116	75	157
Other comp. income net of taxes	-1.4%	-0.46	-0.44	-0.44	-0.39	-0.54	-0.37
Total Comprehensive Income	-88.7%	17	142	63	115	74	157
Earnings Per Share, Basic	-97.2%	1.26	10.43	4.62	8.48	5.46	11.541
Earnings Per Share, Diluted	-97.2%	1.26	10.43	4.62	8.48	5.46	11.541

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020	Mar-2019
Revenue From Operations	-10.2%	2,724	3,034	2,511	1,809	2,230	1,792
Other Income	21.8%	124	102	71	14	7.58	2.6
Total Income	-9.2%	2,848	3,135	2,582	1,823	2,237	1,795
Cost of Materials	-14.4%	1,476	1,725	1,307	778	885	1,028
Employee Expense	8.7%	250	230	197	181	175	159
Finance costs	91.2%	2.09	1.57	1.6	4.12	20	43
Depreciation and Amortization	14.7%	87	76	73	67	78	53
Other expenses	-3.7%	528	548	448	321	370	352
Total Expenses	-6.1%	2,370	2,525	1,940	1,344	1,531	1,582
Profit Before exceptional items and Tax	-21.7%	478	610	642	479	706	212
Exceptional items before tax	-	80	0	0	0	0	0
Total profit before tax	-8.5%	558	610	642	479	706	212
Current tax	-3%	130	134	153	123	192	49
Deferred tax	-205.8%	-5.06	6.73	3.28	0.67	-30.09	26
Total tax	-10.8%	125	140	156	124	162	74
Total profit (loss) for period	-7.7%	433	469	486	355	544	138
Other comp. income net of taxes	54.5%	-1.66	-4.85	0.06	-1.3	-3.66	-2.67
Total Comprehensive Income	-7.1%	432	465	486	353	540	135
Earnings Per Share, Basic	-7.9%	31.78	34.41	35.65	26.01	39.89	10.121
Earnings Per Share, Diluted	-7.9%	31.78	34.41	35.65	26.01	39.89	10.121
Debt equity ratio	-	-	-	-	-	014	-
Debt service coverage ratio	-	-	-	-	-	0.0603	-
Interest service coverage ratio	-	-	-	-	-	0.4191	-

Consolidated figures (in Rs. Crores) / View Standalone Data

QuarterlyAnnual

Description	(%) Q/Q	Dec-2024	Sep-2024	Jun-2024	Mar-2024	Dec-2023	Sep-2023
Revenue From Operations	-6.4%	1,903	2,032	2,167	2,126	2,009	1,778
Other Income	0%	21	21	19	19	14	17
Total Income	-6.3%	1,924	2,053	2,186	2,145	2,023	1,795
Cost of Materials	-8.5%	1,333	1,456	1,413	1,414	1,459	1,093
Purchases of stock-in-trade	-82.9%	14	77	23	1.56	0	31
Employee Expense	1%	98	97	95	93	89	85
Finance costs	-3.6%	6.11	6.3	5.75	4.41	2.93	2.68
Depreciation and Amortization	0%	48	48	47	46	42	39
Other expenses	-4.3%	244	255	262	258	243	225
Total Expenses	0%	1,789	1,789	1,911	1,876	1,749	1,518
Profit Before exceptional items and Tax	-49%	135	264	275	269	274	277
Exceptional items before tax	-	0	0	0	80	0	0
Total profit before tax	-49%	135	264	275	349	274	277
Current tax	-48.6%	37	71	74	84	70	69
Deferred tax	56%	0.04	-1.18	-2.03	11	1.71	3.55
Total tax	-47.8%	37	70	72	95	72	72
Total profit (loss) for period	-49.7%	98	194	203	254	202	205
Other comp. income net of taxes	-9.6%	-0.71	-0.56	-0.44	-0.68	-0.54	-0.37
Total Comprehensive Income	-50.3%	97	194	202	253	202	205
Earnings Per Share, Basic	-53.2%	7.19	14.24	14.85	18.61	14.81	15.04
Earnings Per Share, Diluted	-53.2%	7.19	14.24	14.85	18.61	14.81	15.04

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020	Mar-2019
Revenue From Operations	-3.6%	7,682	7,972	6,802	4,360	4,230	1,792
Other Income	59.6%	76	48	43	22	35	2.6
Total Income	-3.3%	7,758	8,020	6,845	4,381	4,265	1,795
Cost of Materials	-6.3%	5,056	5,395	4,211	2,274	2,348	1,028
Purchases of stock-in-trade	-46.9%	77	144	0	0	0	0
Employee Expense	10.4%	351	318	274	247	219	159
Finance costs	-54.2%	12	25	34	74	115	43
Depreciation and Amortization	0%	166	166	178	153	140	53
Other expenses	-4.5%	971	1,017	810	601	612	352
Total Expenses	-2%	6,736	6,874	5,410	3,340	3,459	1,582
Profit Before exceptional items and Tax	-10.8%	1,022	1,146	1,434	1,042	806	212
Exceptional items before tax	-	80	0	0	0	0	0
Total profit before tax	-3.8%	1,102	1,146	1,434	1,042	806	212
Current tax	5.4%	273	259	353	240	192	49
Deferred tax	-50%	18	35	15	26	3.29	26
Total tax	-1%	291	294	368	266	195	74
Total profit (loss) for period	-4.8%	811	852	1,067	776	611	138
Other comp. income net of taxes	50.8%	-1.95	-5	0.17	-1.07	-3.8	-2.67
Total Comprehensive Income	-4.5%	809	847	1,067	775	607	135
Earnings Per Share, Basic	-4.9%	59.45	62.47	78.2	56.88	44.8	10.12
Earnings Per Share, Diluted	-4.9%	59.45	62.47	78.2	56.88	44.8	10.12
Debt equity ratio	-	-	-	-	-	07	-
Debt service coverage ratio	-	-	-	-	-	0.0427	-
Interest service coverage ratio	-	-	-	-	-	0.0893	-

Description	Share	Value
Phenolics	71.2%	1.4 kCr
Advanced Intermediates	28.8%	551.7 Cr
Total		1.9 kCr

Investor Care
Dividend Yield	0.34%
Dividend/Share (TTM)	7.5
Shares Dilution (1Y)	0.00%
Diluted EPS (TTM)	54.89

Financial Health
Current Ratio	3.8
Debt/Equity	0.15
Debt/Cashflow	4.05

Summary of Latest Earnings Report from Deepak Nitrite

Summary of Deepak Nitrite's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.

Earnings Outlook

Last updated: Feb 25

Management Outlook & Key Points:
Deepak Nitrite's management remains optimistic about recovery and growth despite Q3 challenges, attributing temporary setbacks to plant shutdowns, delayed project commissioning, and raw material cost pressures.

Key Strategic Initiatives & Outlook:

Segmental Recovery:
- Advanced Intermediates: Margins impacted by agrochemical destocking and raw material costs. Demand recovery expected from Q4 FY25, with normalization in margins (17-18%) by Q1/Q2 FY26. New products and expanded capacities to drive volume growth.
- Phenolics: Post-shutdown operations resumed with improved throughput. India's self-reliance in phenol to reduce import dependency. Margins to stabilize as imports normalize and domestic demand grows.
Project Pipeline:
- Near-term: Nitric acid plant commissioning in Q1 FY26 (annual margin boost: ~Rs.70-80 crore). R&D center operational by Q4 FY25.
- Medium-term: MIBK, MIBC, and acetophenone projects (H1 FY26) to expand solvent offerings for energy and pharma sectors.
- Long-term: Polymer value chain integration (polycarbonate resins, BPA) by December 2027, targeting import substitution and export opportunities.
Financial Resilience: Strong balance sheet (net worth: Rs.5,222 crore consolidated) with low leverage to fund expansions. Cost optimization and backward integration (e.g., ammonia sourcing) to enhance margins.
Market Positioning: Focus on sustainability (improved carbon footprint) and customer retention. Government anti-dumping investigations on dye intermediates to support pricing power.

Summary: Management anticipates sequential improvement in Q4 FY25, with full normalization across segments by H1 FY26. Strategic projects and integration efforts aim to solidify leadership in specialty chemicals and polymers, supported by robust domestic demand and operational efficiency.

Q&A Session

Last updated: Feb 25

Question 1:
When we compare our standalone business, the top-line between Q2 to Q3 fell by ~Rs.53 crore, but EBITDA impact was ~Rs.33 crore. Did deferred agro-intermediate sales (higher margin) cause this, or was raw material cost the key driver?
Answer: Agro-intermediate delays (higher margin) and idled plants contributed, but stubborn raw material costs (e.g., toluene, caustic lye) also pressured margins. Demand recovery began in late Q3, with normalization expected in Q4"“Q1.

Question 2:
Can the Q3 lost performance be recouped in Q4, or will recovery spill into Q1?
Answer: Majority of recovery expected in Q4, aided by resumed exports and domestic demand. Partial normalization may extend to Q1.

Question 3:
Provide updates on the nitric acid plant's capex and annual savings. How will ammonia supply be managed?
Answer: Capex aligned with initial plans (delay-related overheads capitalized). Annual margin expansion: Rs.70"“80 crore. Ammonia sourcing diversified via domestic/international contracts and storage infrastructure to mitigate volatility.

Question 4:
Why did Phenolics EBIT drop 40% QoQ? Breakdown volume vs. spread impact.
Answer: Primarily due to scheduled maintenance shutdown (volume loss) and spread compression from imported phenol. Post-shutdown, throughput improved. Spread normalization expected from March.

Question 5:
What drives global phenol spread recovery: demand revival or supply curtailment?
Answer: Indian demand remains robust. Non-integrated global plants face low utilization, but spreads hinge on raw material (benzene, propylene) volatility. No imminent supply cuts anticipated.

Question 6:
Clarify polymer project timelines: phased commissioning or all by FY28?
Answer: All projects (polycarbonate, BPA, etc.) to be integrated and commissioned by FY28. Some components may start earlier but synced for full operational synergy.

Question 7:
When will profitability normalize? What's the volume/margin trajectory?
Answer: Q4 EBITDA to improve "meaningfully" vs. Q3. Full normalization (pre-downturn margins) expected by Q1"“Q2 FY26, driven by demand recovery and cost optimization.

Question 8:
Will Advanced Intermediates' margins face structural decline post-recovery?
Answer: Target normalized standalone EBIT margin of 17"“18% (vs. 3% in Q3), aided by cost initiatives and non-agro diversification (e.g., personal care, solvents).

Question 9:
Confirm Phenolics' annual capacity (350K MT?) and Ag chem intermediate demand outlook.
Answer: Phenolics capacity: ~350K MT annually. Ag chem demand recovery linked to global destockingå°¾å£°, with a 1-quarter lag. Mid-single-digit volume growth expected in CY25.

Question 10:
Address ROCE concerns due to project delays. How to ensure polymer capex execution?
Answer: Delays stemmed from in-house tech integration (e.g., MIBK/MIBC). Future polymer projects (licensed tech) to avoid such issues. ROCE to improve post-commissioning via scale and integration.

Question 11:
Why did Phenolics' revenue dip only 5% despite 15K MT production loss?
Answer: Sales maintained via pre-shutdown inventory. EBIT drop due to shutdown costs (fixed expenses), spread compression, and temporary imports.

Question 12:
Rationale for acetophenone project: backward integration or new market?
Answer: Forward integration into pharma/life sciences via phenol/acetone valorization. Enhances margins and diversifies product mix.

Balance Sheet for Deepak Nitrite

Standalone figures (in Rs. Crores) / View Consolidated Data

Description	(%) Q/Q	Sep-2024	Mar-2024	Sep-2023	Mar-2023	Sep-2022	Mar-2022
Cash and cash equivalents	-98.8%	3.1	173	3.59	16	3.92	7.44
Current investments	301.1%	358	90	279	369	423	437
Loans, current	-82.9%	30	171	101	0.43	0.42	0.41
Total current financial assets	-12.8%	967	1,109	991	1,023	952	1,000
Inventories	13.4%	432	381	429	448	380	339
Total current assets	-5.5%	1,456	1,540	1,479	1,527	1,387	1,393
Property, plant and equipment	5.9%	882	833	750	726	668	672
Capital work-in-progress	-16.8%	105	126	114	77	111	83
Non-current investments	21.7%	1,040	855	799	688	522	472
Loans, non-current	27.8%	1.69	1.54	0.84	0.7	0.63	0.76
Total non-current financial assets	21.7%	1,046	860	806	694	604	478
Total non-current assets	11.8%	2,047	1,831	1,693	1,523	1,394	1,248
Total assets	3.9%	3,503	3,371	3,172	3,050	2,782	2,642
Total non-current financial liabilities	0%	30	30	2.3	10	8.27	9.61
Provisions, non-current	7.1%	31	29	29	26	21	19
Total non-current liabilities	1.9%	110	108	83	93	81	80
Borrowings, current	-	19	0	5.67	0	10	14
Total current financial liabilities	13%	306	271	291	306	262	285
Provisions, current	-25%	13	17	13	14	9.03	7.13
Current tax liabilities	-37.1%	5.02	7.39	0	0	0.87	2.39
Total current liabilities	9.4%	337	308	323	331	286	306
Total liabilities	7.2%	446	416	407	425	367	386
Equity share capital	0%	27	27	27	27	27	27
Total equity	3.5%	3,057	2,955	2,765	2,625	2,415	2,256
Total equity and liabilities	3.9%	3,503	3,371	3,172	3,050	2,782	2,642

Consolidated figures (in Rs. Crores) / View Standalone Data

Description	(%) Q/Q	Sep-2024	Mar-2024	Sep-2023	Mar-2023	Sep-2022	Mar-2022
Cash and cash equivalents	-86.5%	33	238	15	38	63	23
Current investments	230.5%	391	119	502	377	423	437
Loans, current	100%	1.22	1.11	0.82	0.43	0.42	0.41
Total current financial assets	9%	2,121	1,946	1,775	1,766	1,633	1,611
Inventories	20.6%	916	760	726	893	740	585
Current tax assets	-	0.02	0	0	0	6.2	6.16
Total current assets	12.2%	3,189	2,842	2,576	2,739	2,449	2,283
Property, plant and equipment	4.6%	2,346	2,243	1,946	1,914	1,887	1,933
Capital work-in-progress	51.1%	1,169	774	479	283	181	104
Goodwill	-	2.66	0	0	0	0	0
Non-current investments	3.6%	2.75	2.69	2.52	2.48	2.24	2.23
Loans, non-current	9.2%	2.19	2.09	1.16	0.7	0.63	0.76
Total non-current financial assets	-56.2%	15	33	15	14	13	12
Total non-current assets	17.3%	3,819	3,255	2,692	2,390	2,219	2,146
Total assets	15%	7,009	6,096	5,268	5,129	4,669	4,430
Borrowings, non-current	256.9%	772	217	40	43	95	187
Total non-current financial liabilities	198.9%	832	279	44	58	108	200
Provisions, non-current	8.6%	39	36	33	30	24	22
Total non-current liabilities	114.6%	1,046	488	238	245	261	345
Borrowings, current	-	19	0	13	11	159	113
Total current financial liabilities	4.5%	749	717	621	732	709	668
Provisions, current	-18.8%	14	17	14	14	9.4	7.7
Current tax liabilities	381.4%	32	7.44	11	0	3.15	2.39
Total current liabilities	6.9%	839	785	688	794	756	747
Total liabilities	47.9%	1,884	1,274	926	1,039	1,018	1,092
Equity share capital	0%	27	27	27	27	27	27
Non controlling interest	40%	36	26	0	0	0	0
Total equity	6.3%	5,125	4,823	4,342	4,090	3,651	3,338
Total equity and liabilities	15%	7,009	6,096	5,268	5,129	4,669	4,430

Cash Flow for Deepak Nitrite

Standalone figures (in Rs. Crores) / View Consolidated Data

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022
Finance costs	91.2%	2.09	1.57	1.6
Change in inventories	162.4%	67	-104.77	-124.24
Depreciation	14.7%	87	76	73
Unrealised forex losses/gains	509.1%	1.67	1.11	0.01
Dividend income	23%	76	62	39
Adjustments for interest income	1795.6%	8.63	0.55	0.53
Net Cashflows from Operations	20.5%	541	449	380
Income taxes paid (refund)	-11.6%	123	139	152
Net Cashflows From Operating Activities	35%	418	310	228
Cashflows used in obtaining control of subsidiaries	-22.8%	167	216	196
Proceeds from sales of PPE	1671.4%	3.2	0.86	118
Purchase of property, plant and equipment	66.9%	208	125	104
Purchase of intangible assets	113.3%	1.32	1.15	0.31
Cash receipts from repayment of advances and loans made to other parties	-	158	0	0
Dividends received	23%	76	62	39
Interest received	1823.4%	9.1	0.53	0.55
Net Cashflows From Investing Activities	17.1%	-156.16	-188.47	-159.13
Proceeds from borrowings	93.3%	0	-13.99	14
Payments of lease liabilities	-	2.36	0	0
Dividends paid	7.4%	102	95	75
Interest paid	76.5%	0.84	0.32	1.61
Other inflows (outflows) of cash	0%	-0.01	-0.01	0
Net Cashflows from Financing Activities	6.4%	-105.5	-112.83	-64.36
Net change in cash and cash eq.	1923.3%	157	8.71	4.38

Consolidated figures (in Rs. Crores) / View Standalone Data

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022
Finance costs	-63.3%	12	31	38
Change in inventories	142.9%	133	-306.77	-197.75
Depreciation	0%	166	166	178
Unrealised forex losses/gains	-91.9%	1.08	1.99	2.64
Adjustments for interest income	51.6%	4.35	3.21	2.13
Net Cashflows from Operations	25.7%	1,144	910	1,177
Income taxes paid (refund)	2.3%	266	260	353
Net Cashflows From Operating Activities	35.1%	878	650	824
Cashflows used in obtaining control of subsidiaries	-	27	0	0
Proceeds from sales of PPE	3314.3%	3.25	0.93	0.66
Purchase of property, plant and equipment	107.6%	742	358	186
Purchase of intangible assets	1527.9%	29	2.72	0.31
Interest received	138.7%	3.96	2.24	2.22
Other inflows (outflows) of cash	-14360.5%	-218.8	-0.52	0
Net Cashflows From Investing Activities	-160.9%	-721.84	-276.05	-424.06
Proceeds from borrowings	-	217	0	15
Repayments of borrowings	-78.9%	54	252	296
Dividends paid	7.4%	102	95	75
Interest paid	-59.9%	9.82	23	34
Other inflows (outflows) of cash	-106.3%	-0.01	17	5.81
Net Cashflows from Financing Activities	111.9%	44	-359.08	-385.82
Net change in cash and cash eq.	1321.4%	200	15	14

Is Deepak Nitrite Better than it's peers?

Detailed comparison of Deepak Nitrite against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
SRF	SRFSpecialty Chemicals	90.12 kCr	14.07 kCr	+3.44%	+15.13%	78.58	6.4	+4.78%	-22.29%
ALKEM	Alkem LabPharmaceuticals	60.09 kCr	13.19 kCr	+2.95%	+2.35%	27.35	4.55	+2.06%	+39.55%
ATUL	AtulSpecialty Chemicals	19.14 kCr	5.42 kCr	+5.92%	+9.62%	44.77	3.53	+13.37%	+19.56%
VINATIORGA	Vinati OrganicsSpecialty Chemicals	17.42 kCr	2.2 kCr	+6.29%	+2.40%	45.09	7.93	+16.41%	+7.41%
AARTIIND	Aarti IndustriesSpecialty Chemicals	15.72 kCr	7.11 kCr	+10.98%	-42.02%	42.84	2.21	+13.53%	-15.30%
ALKYLAMINE	Alkyl Amines ChemicalsSpecialty Chemicals	9.15 kCr	1.57 kCr	+10.62%	-13.83%	51.27	5.85	+3.61%	+12.23%
BALAMINES	Balaji AminesSpecialty Chemicals	4.17 kCr	1.49 kCr	+6.57%	-42.09%	21.86	2.79	-13.51%	-11.35%

DEEPAKNTR - Deepak Nitrite Limited Share Price

What does Deepak Nitrite Limited do?

Sector Comparison: DEEPAKNTR vs Chemicals & Petrochemicals

Comparative Metrics

Performance Comparison

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

Valuation

Fundamentals

Profitability

Income Statement for Deepak Nitrite

Revenue Breakdown

Investor Care

Financial Health

Summary of Latest Earnings Report from Deepak Nitrite

Balance Sheet for Deepak Nitrite

Cash Flow for Deepak Nitrite

Is Deepak Nitrite Better than it's peers?

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)